GAMZU ELKAN R 4
4 · PHARMOS CORP · Filed Jun 21, 2004
Insider Transaction Report
Form 4
PHARMOS CORPPARS
GAMZU ELKAN R
Director
Transactions
- Sale
Common Stock
2004-06-17$3.88/sh−1,250$4,844→ 0 total - Exercise/Conversion
Common Stock
2004-06-17$1.88/sh+1,250$2,344→ 1,250 total - Exercise/Conversion
Stock Options
2004-06-17−1,250→ 18,750 totalExercise: $1.88From: 2004-04-02Exp: 2011-04-02→ Common Stock (1,250 underlying)
Footnotes (1)
- [F1]Sale is pursuant to a 10b5-1 trading plan previously established by Dr. Gamzu.